TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Scientists have reported that TM6SF2 rs58542926 mutation is one of the important genetic factors leading to NAFLD (32), and it is also associated with advanced hepatic fibrosis/cirrhosis independent of potential confounding factors such as age, BMI, T2D (33).